8 completed. 3 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow imidafenacin: new trials by email Literature Review of imidafenacin trials Research Report on imidafenacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania mirabegron, solifenacin, darifenacin - Overactive Bladder (OAB) | Completed | Astellas Pharma Singapore Pte. Ltd. | 5589 | 2018-07-20 | 2024-10-16 | |
| A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China mirabegron, solifenacin, darifenacin - Overactive Bladder (OAB) | Completed | Astellas Pharma Singapore Pte. Ltd. | 805 | 2018-07-19 | 2020-04-22 | |
| Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. Uritos®, Urotol® - Overactive Bladder | Phase 3 | Completed | R-Pharm | 300 | 2016-07-18 | 2019-05-21 |
| Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. Mirabegron tablet, Solifenacin tablet, Propiverine tablet - Overactive Bladder (OAB) | Phase 4 | Completed | Astellas Pharma Inc | 649 | 2014-10-28 | 2024-10-31 |
| Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder Imidafenacin, Fesoterodine - Overactive Bladder | Phase 4 | Completed | LG Life Sciences | 207 | 2010-12-01 | 2012-04-16 |
| Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder imidafenacin, KRP-197/ONO-8025 - Overactive Bladder | Phase 3 | Completed | Ono Pharmaceutical Co., Ltd. | 435 | 2007-08-01 | 2012-06-13 |
| Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan ONO-8025 (KRP-197) - Overactive Bladder | Phase 3 | Completed | Ono Pharmaceutical Co., Ltd. | 750 | 2003-10-01 | 2012-10-11 |
| Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan ONO-8025 (KRP-197) - Overactive Bladder | Phase 2 | Completed | Ono Pharmaceutical Co., Ltd. | 400 | 2001-10-01 | 2012-10-12 |
Urinary Bladder, Overactive (8) · Urinary Incontinence (1) · Urinary Incontinence, Urge (1)
Ono Pharmaceutical Co., Ltd. (3) · Astellas Pharma Singapore Pte. Ltd. (2) · Astellas Pharma Inc (1) · LG Life Sciences (1) · R-Pharm (1)
South Korea (3) · Japan (2) · Australia (1) · Russia (1) · Taiwan (1)
Project Leader, Development Planning (2) · Mikhail Samsonov (1) · Toshihiko Konomi (1) · Yoshifumi Hirahara (1)